Dividend Growth of Novartis AG(NVS)

Novartis AG(NVS) is having a Dividend Yield of 3.04% with the Annual cash Dividend per share of $2.3. Novartis AG has a 5 year average dividend yield of 2.76% and the stock has a Indicated annual dividend of $2.3. Novartis AG(NVS) formally announced its most recent dividend on January 27, 2017 with a Dividend per share of $2.33. The new indicated annual dividend based on announced dividend per share is $2.33. The dividend yield based on the forward looking indicated annual dividend is 3.07%. Novartis AG(NVS) has the most recent dividend payout ratio of 0.49 with a 5-year average payout ratio of 0.42. Companys change in pay out ratio when compared to the last 5 years average pay out ratio has been 0.07. The 5 year historical dividend growth of Novartis AG(NVS) is at the rate of 2.65% while the R-Squared dividend growth is 0.18. If the value of R-Square is close to one, it indicates a perfect fit and the higher value conforms to the regression line while data close to zero indicates the opposite.

Novartis AG (NYSE:NVS) rose 1.19% or 0.9 points on Thursday and made its way into the gainers of the day. After trading began at $76.44 the stock was seen hitting $76.75 as a peak level and $76.13 as the lowest level. The stock ended up at $76.73. The daily volume was measured at 2,497,879 shares. The 52-week high of the share price is $83.58 and the 52-week low is $66.93. The company has a market cap of $182,162 million. Shares of Novartis AG rose by 2.14% in the last five trading days and 6.73% for the last 4 weeks. Novartis AG is up 6.72% in the last 3-month period. Year-to-Date the stock performance stands at 5.34%.

Currently the company Insiders own 0.01% of Novartis AG shares according to the proxy statements. Institutional Investors own 9.82% of Novartis AG shares. Several Stock Research Financial Advisors from Investment Banking firms have advised their client and investors on the stock.Novartis AG (ADR) was Downgraded by Berenberg to Hold on Jan 17, 2017. Novartis AG (ADR) was Downgraded by Credit Suisse to Neutral on Jan 11, 2017.

Novartis AG (ADR) Last issued its quarterly earnings results on Jan 25, 2017. The company reported $1.14 EPS for the quarter, beating the analyst consensus estimate by $ 0.02. Analyst had a consensus of $1.12. The company had revenue of $12322.00 million for the quarter, compared to analysts expectations of $12440.65 million. The companys revenue was down -1.6 % compared to the same quarter last year.During the same quarter in the previous year, the company posted $1.12 EPS.

Novartis AG is committed to improving health and well-being through innovative products and services. The company aspires to capture and hold a leadership position in all of their businesses with a strong, sustainable performance based on continuous innovation. Their long-term success is founded on meeting the expectations of all our stakeholders – their customers, their people, their shareholders and the communities in which they live and work.

Novartis

Post Comment